Antigenic Variation Sample Clauses

The Antigenic Variation clause defines the process by which an organism, typically a pathogen, alters its surface proteins to evade detection by the host's immune system. In practice, this clause applies to biological agreements or research protocols, specifying how changes in antigenic properties are identified, monitored, or reported during the course of a study. Its core function is to address the challenge of immune evasion, ensuring that parties are aware of and can respond to changes in pathogen behavior that may impact research outcomes or therapeutic effectiveness.
Antigenic Variation mirabilis encodes two nearly identical flagellins, ▇▇▇▇ and flaB. A third putative flagellin is encoded elsewhere on the chromosome. Despite the close proximity of the two loci, ▇▇▇▇ is transcribed monocistronically, and flaB transcript is scarce in wild-type cells. ▇▇▇▇ is the major flagellin, as ▇▇▇▇ mutants are non-motile and do not synthesize flagellin while flaB mutants exhibit wild-type motility. Mutants of ▇▇▇▇ frequently revert to motile cells with a flagellum that is antigenically distinct from wild-type (89). These mutants have hybrid FlaAB flagellin created by deletions in both loci that place the active ▇▇▇▇ promoter and the 5’coding region of ▇▇▇▇ with homologous and previously silent regions of flaB (90). Later, it was shown P. mirabilis populations are naturally heterogeneous in flagellar composition, with 1.0–1.5% of the population expressing hybrid flaAB transcript (91). Flagellin rearrangements confer advantages in different environments; bacteria with hybrid FlaAB flagella are more motile in environments with high salinity and extreme pH, while bacteria with ▇▇▇▇ flagella are more motile in low salt conditions (92). Recovery of swimmer and swarmer cells from the murine urinary tract illustrated different hybrid flagellins are formed during infection. All recovered FlaAB proteins were the result of splicing before the antigenically exposed domain of the flagellin molecule. This would result in exposure of different antigenic sites on the surface of the bacterium (90), and both flagellin proteins are capable of generating a humoral response (61). Overall, the ability of P. mirabilis to undergo flagellin rearrangements promotes survival in various environments and may help the bacteria evade the immune response during UTI.
View Source

Related to Antigenic Variation

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Protocol The attached Protocol shall be an integral part of this Agreement.

  • Preceptor A per diem Registered Nurse 2 may serve as a preceptor after successfully completing a preceptor workshop or equivalent documented training and agreeing to and being appointed to be specifically responsible for planning, organizing, and evaluating the new skill development of one or more RNs as appropriate enrolled in a defined orientation program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the new or transferring employee. The per diem RN 2 preceptor is eligible to receive preceptor premium pay when actually engaged in preceptor role responsibilities with/on behalf of the orienting RN. A per diem RN 2 substituting for the original preceptor during a period of absence and who has been designated to carry out the preceptor's complete responsibility (including following and/or adjusting the plan to meet learning needs and providing oral and written evaluation input) will receive preceptor pay. A preceptor may be assigned to a student when it is determined by the Employer that the employee has completed the required preceptor training or has agreed to and been appointed a preceptor. The employee is specifically responsible for planning, organizing, and evaluating the new skill development of the student as appropriately enrolled in a defined program, the parameters of which have been set forth in writing by the Employer. This includes teaching, clinical supervision, role modeling, feedback, evaluation (verbal and written) and follow up of the student.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Volunteer Firefighting Leave Leave without pay will be granted when an employee who is a volunteer firefighter is called to duty to respond to a fire, natural disaster or medical emergency.